Animal (gastrointestinal) · PMID 16075683
Effect of peptide Livagen on activity of digestive enzymes in the gastrointestinal tract — VialBase Research
Animal evidence for Livagen's gastrointestinal/digestive activity.
Last updated · 2005 · Timofeeva NM et al. · Adv Gerontol
Key findings
- Livagen altered activity of digestive enzymes in the gastrointestinal tract
- Supports tissue-regulatory effects beyond the liver in the Cytogen's profile
Livagen and digestive-enzyme activity (PMID: 16075683)
Summary
Livagen modulated digestive-enzyme activity in the gastrointestinal tract in an animal model, consistent with tissue-specific regulatory effects.
Relevance
Named, compound-specific animal study supporting Livagen‘s digestive/hepatic positioning.
See Also
- Parent compound: Livagen
Where to buy Livagen
Livagen4 vetted vendors
BioLongevity LabsVisit BioLongevity Labs →
Save 15% with code VIALBASE
VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.